$Ironwood Pharmaceuticals (IRWD.US)$Revenue has fluctuated a...

逍遥投资派 commented on a stock · May 22, 2023 22:27

$Ironwood Pharmaceuticals (IRWD.US)$Revenue has fluctuated but grown over the past 5 years, with an average growth rate of 6.6%. Operating profit turned around in 2019 and has continued to grow for 4 years, with an average growth rate of 28.8% in the past 3 years. The growth rate in 2022 declined to 7.8%. Net income was impacted by income tax refunds and reached 530 million in 2021, with an average growth rate of 100% in the past 3 years and 28% in the past 2 years.

The income statement shows that interest changed from an expense to income in 2022, eliminating the interest burden.

In 2023Q1, revenue grew by 6.7%, operating profit by 3.9%, and net income by 17.8%.

Over the past 5 years, the asset-liability ratio has dropped from 159% to 40.7%, further decreasing to 38.8% in Q1 2023.

The balance sheet shows that cash at the end of 2022 reached 0.66 billion, long-term borrowing 0.396 billion, which should be the reason for the disappearance of interest burden. In Q1 2023, cash reached 0.74 billion, long-term borrowing 0.397 billion, cash increased further. No inventory, accounts receivable growth rate and ratio are both normal.

In the past 3 years, the cash flow from operating activities far exceeded the net investment amount, indicating extremely strong cash generation ability.

Currently, the PE ratio is 10.4, PE ratio TTM has dropped to 10, a (⭐️⭐️) can be selected.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

See Original

Report

6711 Views

Comment

逍遥投资派

565Followers

35Following

3124Visitors